vp-india-2026-sep-oct

Elevates the standard of care 9 out of 10 children showed no clinically relevant myopia progression in the first 12 months of wear. Built on over a decade of clinical expertise Developed through sustained scientific research, D.I.M.S. Technology is backed by 100+ peer-reviewed publications, 8 years of long-term data, and an ongoing partnership with The Hong Kong Polytechnic University. Moving closer to effective myopia control Early results are highly promising. As data and global adoption continue to grow, MiYOSMART iQ represents a meaningful step towards reducing the impact of progressive myopia on children’s vision. MiYOSMART iQ redefines what is possible Let's raise the bar in myopia control For more information about MiYOSMART iQ, scan the QR code or visit hoyavision.com ©2026 Hoya Corporation. All rights reserved. Improve life through vision